Proper storage and handling of GLP-1 receptor agonist injectable medications is essential to ensure that each dose delivers the correct amount of active drug. Semaglutide (Wegovy) and tirzepatide (Zepbound) are protein-based biologics — complex molecular structures that can be degraded or inactivated by improper temperature, light exposure, or physical agitation. Understanding the storage requirements protects your investment in these high-cost medications and ensures treatment efficacy.
Refrigerated Storage: The Primary Requirement
Both Wegovy and Zepbound pens must be stored under refrigerated conditions when not in use. The correct temperature range for storage is 2°C to 8°C (36°F to 46°F) — standard household refrigerator temperature. Specific storage guidelines include:
- Store pens in the original carton with the pen cap attached to protect from light exposure.
- Keep the medication on a middle shelf of the refrigerator — not in the door, where temperature fluctuates more with each opening, and not in the crisper drawer or at the very back, where freezing can accidentally occur.
- Do not place the pen on ice or adjacent to a freezer compartment inside the refrigerator.
- Medication that has been frozen must not be used — freezing can denature the protein structure of semaglutide and tirzepatide, rendering the dose ineffective even though the pen may appear visually normal. There is no reliable way to visually distinguish a frozen-and-thawed pen from an intact one.
Room Temperature Storage: The In-Use Period
Once a pen has been removed from refrigerator storage (or is being prepared for travel), it may be stored at room temperature for a limited period. The specific allowances differ between products:
- Wegovy (semaglutide 2.4 mg): May be stored at room temperature up to 30°C (86°F) for up to 28 days after first removal from refrigerator. After 28 days at room temperature, the pen must be discarded even if medication remains in it.
- Zepbound (tirzepatide): May be stored at room temperature up to 30°C (86°F) for up to 21 days after first removal from refrigerator. After 21 days at room temperature, the pen must be discarded.
These are manufacturer-specified and FDA-approved stability windows. Patients should write the date of removal from the refrigerator on the pen label or in a medication log to ensure they do not exceed the room temperature storage period.
💡 💡 Clinical Pearl
A common patient error is leaving the pen on a bathroom counter or windowsill for extended periods — places where temperature can exceed 30°C (86°F) in summer months or in warm climates. Exposure to temperatures above the storage limit accelerates drug degradation even if the pen is within the calendar time limit. If you live in a warm climate or your home is frequently above 30°C without air conditioning, prioritize keeping the pen refrigerated between injections and only bring it to room temperature in the 15–30 minutes immediately before injection.
Protection from Light and Physical Damage
Like most biological medications, GLP-1 RA pens should be protected from direct sunlight and ultraviolet light exposure. Extended UV exposure can damage the peptide structure. Always:
- Keep the pen cap on when not in use
- Store in the original opaque carton until ready to use
- Avoid leaving the pen on window ledges, in direct sunlight, or in a car on warm days
Physical handling precautions are also important:
- Do not shake the pen vigorously — agitation can denature protein-based drugs
- Do not drop the pen onto hard surfaces; a damaged pen mechanism may not deliver the dose correctly
- Inspect the solution window before each use: the medication should be clear and colorless. Do not use if it appears cloudy, colored, or contains particles.
Traveling with GLP-1 RA Medications
Travel presents particular challenges for medication temperature management. Key recommendations for patients traveling with Wegovy or Zepbound include:
- Air travel (carry-on bags): The Transportation Security Administration (TSA) and equivalent agencies internationally permit injectable medications in carry-on luggage, with a prescription label or documentation recommended. Do NOT check medications in hold luggage — aircraft cargo holds can reach temperatures well below freezing, which would destroy the medication.
- Keep it with you: Medications should travel in your personal carry-on or personal item bag, not in checked luggage.
- Use an insulated travel case: Specialized medication travel cooling cases with gel packs (not ice directly in contact with the pen) can maintain appropriate temperature for 8–24 hours during transit. Evaporative cooling pouches designed for injectable medications are also suitable.
- International destinations: If traveling across time zones, maintain your weekly injection schedule as closely as possible. Minor adjustments of 1–2 days in injection timing are generally acceptable — discuss specifics with your prescriber.
- Hotel accommodation: On arrival, request that the hotel refrigerator be set to the correct temperature range, or ask the hotel concierge to store the medication in the restaurant or kitchen refrigerator if a room unit is not available.
Expiry Dates and Unused Medication Disposal
Never use a pen that has exceeded its labeled expiry date, regardless of how it was stored. The expiry date is printed on the pen label and outer carton and reflects the manufacturer’s validated stability period under recommended storage conditions. Key considerations:
- Pens stored continuously under refrigerated conditions can be used until the expiry date printed on the label.
- Pens that have been at room temperature for longer than the approved period (28 days for Wegovy; 21 days for Zepbound) must be discarded regardless of the printed expiry date.
- Unused, unexpired medication should be disposed of via an FDA-approved medication take-back program or a household sharps/medication disposal site. Do not flush injectable medications down the toilet or pour them into drains unless specifically directed by the package insert.
For more information on correct injection procedure, see How to Inject GLP-1 RA Medications Correctly. For questions about dosing schedules, see Step-by-Step Dosing and Titration Guide.
💡 Frequently Asked Questions (FAQ)
Q1: My pen was accidentally left out of the refrigerator for 3 days. Is it still safe to use?
A1: If the pen was stored at temperatures below 30°C (86°F) during that period, it remains within the room-temperature stability window (28 days for Wegovy, 21 days for Zepbound) and can continue to be used. Note the date of removal from the fridge and count the days accordingly. If the pen was exposed to temperatures above 30°C (such as in a hot car), it should be discarded and replaced, as drug stability cannot be guaranteed.
Q2: Can I put the pen back in the refrigerator after it has been at room temperature?
A2: Yes — for Wegovy, the pen may be moved between room temperature and refrigerator as needed within the 28-day room temperature limit. The same applies to Zepbound within its 21-day window. However, the cumulative time spent at room temperature still counts toward the limit regardless of refrigerator intervals.
Q3: What if I’m traveling somewhere with no refrigeration access for more than 28 days?
A3: Extended travel without refrigeration access requires advance planning. Options include: using medical-grade insulated coolers with regularly replenished ice packs (maintaining 2–8°C), coordinating with a pharmacist at your destination to obtain fresh supply locally, or discussing with your prescriber whether a brief planned interruption in therapy is the safest option. Do not use medication that has been outside the approved storage conditions for the specified duration.
📚 References & Sources
- FDA. (2021). Prescribing Information: Wegovy (semaglutide) injection 2.4 mg. U.S. Food and Drug Administration.
- FDA. (2023). Prescribing Information: Zepbound (tirzepatide) injection. U.S. Food and Drug Administration.
- Müller, T.D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130.